Dr. Chunyan Chen 陈春燕
Chief Physician
Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Precision radiotherapy and individualized treatment for head and neck tumors, including nasopharyngeal, oropharyngeal, oral, laryngeal, hypopharyngeal, nasal cavity, paranasal sinus, adenoid cystic, and salivary gland cancers, as well as lymphoma and metastases.
Dr. Chen has worked in the Department of Radiotherapy at Sun Yat-sen University Cancer Center since 2006, focusing on head and neck tumors. Dr. Chen graduated from Sun Yat-sen University in 2006 and earned a PhD in Oncology there in 2013. From 2013 to 2014, Dr. Chen was a visiting scholar in the Department of Radiotherapy at MD Anderson Cancer Center in the US.
Professional roles
- Secretary-General, Ionizing Radiation Therapy Branch, China Association of Medical Equipment
- Vice Chair, Radioimmunotherapy Youth Committee, China Cancer Radiotherapy Alliance
- Vice Chair, Youth Committee, Oncology Branch, Guangdong Medical Association
- Standing Committee Member, Head and Neck Tumor Professional Committee, Guangdong Anti-Cancer Association
Name order: in Chinese the family name comes first (Chen Chunyan). Papers usually list the name as Chunyan Chen or Chen C.
Selected publications
31 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Ther Adv Med Oncol, 2025 (senior author): Anti-programmed death-1 inhibitors and nimotuzumab in combination with induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis. PubMed 39896749
- iScience, 2023 (senior author): Radiomics and dosiomics for predicting radiation-induced hypothyroidism and guiding intensity-modulated radiotherapy. PubMed 38047064
- Ther Adv Med Oncol, 2023 (senior author): Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy. PubMed 37323188
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion